Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03576417
Title	A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck (NIVOPOSTOP)
Acronym	NIVOPOSTOP
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Groupe Oncologie Radiotherapie Tete et Cou
Indications	laryngeal squamous cell carcinoma oropharynx cancer hypopharynx cancer head and neck squamous cell carcinoma oral squamous cell carcinoma
Therapies	Cisplatin Cisplatin + Nivolumab
Age Groups:	adult \| senior
Covered Countries	FRA